| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC3943 |
| Trial ID | NCT06500819 |
| Disease | Neuroblastoma | Sarcoma | Osteosarcoma |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B7-H3 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I Clinical Trial of Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Children and Young Adults With Relapsed or Refractory Solid Tumor Expressing B7-H3 Target |
| Year | 2024 |
| Country | United States |
| Company sponsor | Stanford University |
| Other ID(s) | IRB-74070 |
| Cohort 1 | |||||||||||||
|
|||||||||||||